HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Runping Liu Selected Research

saikosaponin D

8/2022Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARĪ± and INSIG/SREBP1c pathway.
11/2021Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease.
11/2018A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Runping Liu Research Topics

Disease

16Inflammation (Inflammations)
10/2021 - 06/2014
12Liver Diseases (Liver Disease)
08/2022 - 11/2016
9Neoplasms (Cancer)
10/2021 - 09/2014
8Fibrosis (Cirrhosis)
10/2021 - 11/2017
6Cholestasis
11/2020 - 09/2014
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2017
4Cholangiocarcinoma
01/2018 - 09/2014
2Metabolic Diseases (Metabolic Disease)
08/2022 - 11/2017
2Dysbiosis
01/2020 - 10/2016
2Neuroinflammatory Diseases
01/2020 - 10/2016
1Fatty Liver
08/2022
1Non-alcoholic Fatty Liver Disease
11/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021
1Virus Diseases (Viral Diseases)
10/2021
1Endocrine System Diseases (Endocrine Diseases)
10/2021
1Wounds and Injuries (Trauma)
05/2021
1Pain (Aches)
05/2021
1Hemorrhoids
05/2021
1Hepatocellular Carcinoma (Hepatoma)
04/2021
1Colitis
04/2021
1Hepatitis B
01/2021
1Sclerosing Cholangitis
11/2020
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2020
1Biliary Atresia
11/2019
1Chemical and Drug Induced Liver Injury
01/2019
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2019
1Barrett Esophagus (Barrett's Esophagus)
01/2018
1Adenocarcinoma
01/2018
1Pathologic Processes
11/2017
1Endotoxemia
11/2017
1Hepatitis
04/2017

Drug/Important Bio-Agent (IBA)

9Bile Acids and Salts (Bile Acids)IBA
08/2022 - 06/2014
4Therapeutic UsesIBA
11/2021 - 03/2020
4Long Noncoding RNAIBA
11/2020 - 10/2019
4Sphingosine-1-Phosphate ReceptorsIBA
01/2018 - 09/2014
4Estrogens (Estrogen)FDA Link
01/2017 - 08/2016
3saikosaponin DIBA
08/2022 - 11/2018
3AntioxidantsIBA
01/2021 - 11/2018
3Taurocholic Acid (Sodium Taurocholate)IBA
01/2018 - 04/2015
3AMP-Activated Protein KinasesIBA
11/2017 - 08/2016
3Small Interfering RNA (siRNA)IBA
01/2017 - 01/2017
2Silver Sulfadiazine (SSD)FDA LinkGeneric
11/2021 - 11/2018
2Bupleurum root extractIBA
11/2021 - 04/2017
2Anti-Bacterial Agents (Antibiotics)IBA
05/2021 - 01/2020
2AntigensIBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2018
2gamma-Aminobutyric Acid (GABA)IBA
01/2020 - 01/2019
2Messenger RNA (mRNA)IBA
01/2019 - 01/2018
2sphingosine kinaseIBA
01/2019 - 04/2015
2AmmoniaIBA
01/2019 - 10/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 11/2017
2HIV Protease InhibitorsIBA
01/2015 - 01/2014
1AnthraquinonesIBA
10/2021
1Emodin (Archin)IBA
10/2021
1Indicators and Reagents (Reagents)IBA
04/2021
1TanninsIBA
04/2021
1Complex MixturesIBA
04/2021
1shigyaku-san (Si-Ni-San)IBA
04/2021
1Interferon Type IIBA
04/2021
1phenolic acidIBA
01/2021
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Aspartic Acid (Aspartate)FDA Link
01/2021
1EsterasesIBA
01/2021
1Biological ProductsIBA
01/2021
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2021
1EnzymesIBA
01/2021
1ferulic acid (sodium ferulate)IBA
01/2021
1Chlorogenic AcidIBA
10/2020
1scoparoneIBA
10/2020
1FlavonoidsIBA
10/2020
1capillarisinIBA
10/2020
1rutecarpineIBA
03/2020
1evodiamineIBA
03/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1BerberineIBA
01/2020
116S Ribosomal RNAIBA
01/2020
1isoquinolineIBA
01/2020
1AlkaloidsIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
10/2019
1Pharmaceutical PreparationsIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1N-acetylaspartate (N-acetyl aspartate)IBA
01/2019
1Transcription Factor CHOPIBA
01/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2018
1Antimicrobial PeptidesIBA
11/2017
1Amino AcidsFDA Link
11/2017
1Adenosine Triphosphate (ATP)IBA
11/2017
1CytokinesIBA
11/2017

Therapy/Procedure

6Therapeutics
08/2022 - 01/2015
3Ligation
05/2021 - 01/2018
3Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2020 - 01/2019
1Liver Transplantation
08/2022
1Investigational Therapies (Experimental Therapy)
11/2021
1Perioperative Period
05/2021
1Oral Medicine
05/2021
1Immunotherapy
04/2021
1Molecular Targeted Therapy
01/2021
1Fecal Microbiota Transplantation
01/2020